Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differences in Hypersensitivity Reactions to Iodinated Contrast Media: Analysis of the US Food and Drug Administration Adverse Event Reporting System Database
Xiu‐Xian Lin, Jianhui Yang, Lizhu Weng, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1494-1502.e6
Open Access | Times Cited: 18

Showing 18 citing articles:

Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA’s adverse event reporting system: a case control pharmacovigilance study
Wanlong Lin, Yanbin Zeng, Lizhu Weng, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 10
The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database
Huiping Hu, Maochang Liu, Zhiwen Fu, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Differences in hypersensitivity reactions and gadolinium deposition disease/symptoms associated with gadolinium exposure to gadolinium-based contrast agents: new insights based on global databases VigiBase, FAERS, and IQVIA-MIDAS
Han Qu, Wenjing Li, Zhenhua Wu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
A Scientific Approach to Hemorrhage Risk Assessment of SSRIs/SNRIs Utilizing the FAERS Database
X. Y. Zhou, Shixin Xiang, Bangtian Xu, et al.
Psychiatry Research (2025) Vol. 346, pp. 116388-116388
Closed Access
Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system
Lurong Yu, Qiu-Lian Xiang, Limei Liu
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0314970-e0314970
Open Access
Hypersensitivity reactions to iodinated contrast media: potential mechanisms and clinical management
Xia Zhong, Lihong Zhao
Frontiers in Medicine (2025) Vol. 12
Open Access
Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of Clostridium difficile Infection Associated with Antibacterial Drug Exposure
Dongxuan Li, Yi Song, Zhanfeng Bai, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1109-1109
Open Access | Times Cited: 9
A multifunctional bimetallic nanoplatform for enhancing radiotherapy via oxidative damage and ferroptosis of cervical cancer
Dongzhou Wang, Ze Wang, Xiaojun Ren, et al.
Separation and Purification Technology (2024) Vol. 338, pp. 126567-126567
Open Access | Times Cited: 3
Exploration of adverse events associated with risdiplam use: Retrospective cases from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database
Lurong Yu, Limei Liu
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0298609-e0298609
Open Access | Times Cited: 3
A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system
Huqun Li, Chongshu Wang, Aiping Deng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Does the Risk of Hypersensitivity Reactions to Iopromide Differ by Sex, Race or across Regions/Countries? An Analysis of 152,233 Patients from Four Observational Studies and the Company’s Pharmacovigilance Database
Jan Endrikat, Alexander Ullmann, Christoph Gerlinger, et al.
British Journal of Radiology (2024) Vol. 97, Iss. 1164, pp. 2004-2014
Open Access | Times Cited: 1
High risks adverse events associated with usage of aspirin in chronic obstructive pulmonary disease
Xiaohua Li, Bin Dai, Qingbing Han, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 12, pp. 1285-1295
Closed Access | Times Cited: 1
Case Report: A Rare Case of Iodixanol-Induced Anaphylactic Shock in Cerebral Angiography
Yang Zhao, Hua Wang, Zhengjun Wu, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 361-367
Open Access
Identification of peroneal artery perforators using non-contrast-enhanced T2prep multi-shot gradient echo planar imaging MRA
Yutaka Shigenaga, Takeo Osaki, Nobuyuki Murai, et al.
Radiological Physics and Technology (2024) Vol. 17, Iss. 3, pp. 610-619
Closed Access
Toxicity profiles of immune checkpoint inhibitors in nervous system cancer: a comprehensive disproportionality analysis using FDA adverse event reporting system
Rongrong Liu, Hui Zhao, Zenghong Lu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
A pharmacovigilance analysis of post-marketing safety of tezepelumab
Huqun Li, Chongshu Wang, Cuilian Guo
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 13, Iss. 3, pp. 551-558.e6
Closed Access
Anaphylactic risk associated with iodinated and gadolinium-based contrast media
Sainan Bian, Zixi Wang, Lisha Li, et al.
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access
Iodinated contrast media: risks of hypersensitivity reactions vary

Reactions Weekly (2023) Vol. 1944, Iss. 1, pp. 10-10
Closed Access
Page 1

Scroll to top